An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's disease

Suessmuth, SD; Haider, S; Landwehrmeyer, GB; Farmer, R; Frost, C; Tripepi, G; Andersen, CA; di Bacco, M; Lamanna, C; Diodato, E; +18 more... Massai, L; Diamanti, D; Mori, E; Magnoni, L; Dreyhaupt, J; Schiefele, K; Craufurd, D; Saft, C; Rudzinska, M; Ryglewicz, D; Orth, M; Brzozy, S; Baran, A; Pollio, G; Andre, R; Tabrizi, SJ; Darpo, B; Westerberg, G; (2014) An exploratory double-blind, randomized clinical trial with selisistat, a SirT1 inhibitor, in patients with Huntington's disease. British journal of clinical pharmacology, 79 (3). pp. 465-476. ISSN 0306-5251 DOI: https://doi.org/10.1111/bcp.12512

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1111/bcp.12512

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar